Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Cevimeline
Drug ID BADD_D00424
Description Cevimeline is a parasympathomimetic agent that act as an agonist at the muscarinic acetylcholine receptors M1 and M3. It is indicated by the Food and Drug Administration for the treatment of dry mouth associated with Sjögren's syndrome.
Indications and Usage For the treatment of symptoms of dry mouth in patients with Sjögren's Syndrome.
Marketing Status Prescription; Discontinued
ATC Code N07AX03
DrugBank ID DB00185
KEGG ID D07667
MeSH ID C059240
PubChem ID 2684
TTD Drug ID D0Q4CS
NDC Product Code 63304-479; 64642-011
Synonyms cevimeline | 2-methyspiro(1,3-oxathiolane-5,3)quinuclidine | AF 102B, (trans)-isomer | AF-102B | AF 102B | AF102B | Evoxac | FKS 508 | FKS-508 | SNI 2011 | SNI-2011 | AF 102B, (cis-(+))-isomer | cevimeline hydrochloride
Chemical Information
Molecular Formula C10H17NOS
CAS Registry Number 124620-88-8
SMILES CC1OC2(CN3CCC2CC3)CS1
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Melaena24.07.02.013; 07.12.02.004--Not Available
Menopausal symptoms21.02.02.002--Not Available
Menorrhagia21.01.03.002--
Menstrual disorder21.01.01.004--Not Available
Mental disability26.01.01.001--Not Available
Metrorrhagia21.01.01.006--Not Available
Micturition disorder20.02.02.005--Not Available
Migraine17.14.02.001; 24.03.05.003--Not Available
Mood swings19.04.03.001--Not Available
Motion sickness04.04.01.001; 17.02.12.001--Not Available
Mouth haemorrhage24.07.02.014; 07.05.02.001--
Mouth ulceration07.05.06.004--Not Available
Mucosal inflammation08.01.06.002--Not Available
Multiple sclerosis17.16.01.001; 10.04.10.008--Not Available
Muscle contractions involuntary15.05.03.008; 17.05.03.001--Not Available
Muscle spasms15.05.03.004--
Muscular weakness17.05.03.005; 15.05.06.001--
Myalgia15.05.02.001--
Mydriasis17.02.11.003; 06.05.03.004--Not Available
Myocardial infarction02.02.02.007; 24.04.04.009--
Myopia06.02.04.002--Not Available
Nail discolouration23.02.05.001--
Nail disorder23.02.05.002--
Nasal ulcer22.04.03.011--Not Available
Nausea07.01.07.001--
Neoplasm16.16.02.001--Not Available
Nephrolithiasis20.04.01.002--
Nephrotic syndrome20.05.01.002--
Nervous system disorder17.02.10.001--Not Available
Neuralgia17.02.07.005--
The 8th Page    First    Pre   8 9 10 11 12    Next   Last    Total 15 Pages